methenamine hippurate

DRUG4 trials

Sponsors

Consorci Mar Parc De Salut De Barcelona, University of Pennsylvania, Endeavor Health, Women and Infants Hospital of Rhode Island

Conditions

Catheter-Related InfectionsOveractive Bladder (OAB)Urinary Tract Infection (Diagnosis)Urinary Tract InfectionsUrinary Tract Infections, Recurrentrecurrent urine infections

Phase 4

Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs

CompletedNCT03077711

Endeavor HealthUrinary Tract Infections, Recurrent

Start: 2016-06-30End: 2019-06-21Updated: 2020-01-14

Methenamine Hippurate Following Intradetrusor OnabotulinumtoxinA Injection

Not yet recruitingNCT06953271

Women and Infants Hospital of Rhode IslandOveractive Bladder (OAB), Urinary Tract Infection (Diagnosis)

Start: 2025-05-15End: 2027-01-01Target: 164Updated: 2025-05-01

Randomized, multicenter, open-label clinical trial to evaluate the clinical and microbiological impact of methenamine hippurate as an alternative prophylaxis to antibiotics in the management of recurrent urinary tract infections in women

Not yet recruitingCTIS2025-523922-42-00

Consorci Mar Parc De Salut De Barcelonarecurrent urine infections

Target: 204Updated: 2026-03-25

Unknown Phase

Short-course Methenamine Hippurate for Prevention of Post-operative UTI

CompletedNCT02358993

University of PennsylvaniaCatheter-Related Infections, Urinary Tract Infections

Start: 2014-12-31End: 2020-09-30Updated: 2022-02-25